TITLE

Acute liver failure in a patient with lung cancer

AUTHOR(S)
Jamil, K. M.; Van Hagan, T.; Trotter, J.; Cheng, W.; Kontorinis, N.
PUB. DATE
September 2007
SOURCE
Gut;Sep2007, Vol. 56 Issue 9, p1190
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A quiz concerning the acute liver failure in a patient with lung cancer is presented.
ACCESSION #
26437223

 

Related Articles

  • EDITOR'S QUIZ: GI SNAPSHOT: Answer.  // Gut;Sep2007, Vol. 56 Issue 9, p1209 

    The article focuses on the significance of echocardiogram in treating patient with non-small-cell lung cancer. Echocardiogram demonstrates a pericardial effusion with cardiac tamponade. This could be attributed in ischaemic hepatitis (IH) and acute liver failure (ALF). Here, an emergency...

  • Profound Hypocalcemia in Fulminant Hepatic Failure. Oswiecimski, Paul; Khan, Abdul; Salwan, Rajesh; Marshall, Roland; Berkelhammer, Charles // American Journal of Gastroenterology;Mar2000, Vol. 95 Issue 3, p824 

    Discusses profound hypocalcemia in fulminant hepatic failure. Information on the case of a 71-year-old female smoker who developed profound hypocalcemia complicating fulminant hepatic failure due to small cell carcinoma of the lung; Explanation of fulminant hepatic failure caused by malignancy;...

  • Game Changers.  // Ulster Medical Journal;Jan2014, Vol. 83 Issue 1, p69 

    The article presents insights from several physicians concerning various medical conditions. Doctor Ian Cadden discussed the use of rifaximin in the treatment of hepatic encephalopathy (HE) and overt encephalopathy. Doctors Kathy Cullen and Tim Warke discussed the use of endobronchial...

  • Felbamate and Liver Failure.  // American Family Physician;2/1/1995, Vol. 51 Issue 2, p549 

    Reports on the association of the drug felbamate with the risk of acute liver failure. Recommendation of the United States Food and Drug Administration that the drug remain available only for epileptics; Need for liver function tests prior to initiation of therapy.

  • Acute Liver Failure. Lee, William M. // New England Journal of Medicine;12/16/93, Vol. 329 Issue 25, p1862 

    Highlights recent advances in the understanding and management of acute liver failure. Hepatic encephalopathy and coagulopathy; Statistics on the incidence of acute liver failure in the United States; Viral hepatitis and other causes; Clinical features; Partial list of drugs implicated in...

  • Fulminant hepatic failure induced by lamotrigine. Makin, A.J.; Williams, Roger // BMJ: British Medical Journal (International Edition);7/29/95, Vol. 311 Issue 7000, p292 

    Reports on the case of a woman diagnosed with fulminant hepatic failure as a result of taking lamotrigine. Physiologic effect of lamotrigine; Findings of liver biopsy; Recommendation.

  • Sevoflurane.  // Reactions Weekly;3/20/2010, Issue 1293, p44 

    The article describes the case of fatal subacute liver failure in a 66-year-old woman following treatment with sevoflurane general anaesthesia twice in 25 days.

  • Propylthiouracil/thiamazole.  // Reactions Weekly;9/18/2010, Issue 1319, p40 

    The article describes the case of a 34-year-old woman who developed liver failure after receiving treatment with thiamazole and propylthiouracil for hyperthyroidism.

  • Accurate prediction of fulminant hepatic failure in severe acute viral hepatitis: multicenter study. Yoshiba, Makoto; Sekiyama, Kazuhiko; Inoue, Kazuaki; Yamada, Masaya; Kako, Makoto; Nagai, Kozo; Takatori, Masao; Iwabuchi, Shogo; Sumino, Yasukiyo; Tanaka, Katsuaki; Hakozaki, Yukiya; Hasegawa, Kiyoshi; Shibuya, Akitaka // Journal of Gastroenterology;2002, Vol. 37 Issue 11, p916 

    Background. We have attempted to predict the development of fulminant hepatic failure at the stage of severe acute hepatitis before the onset of coma. This prediction is valuable because it may be used to block the development of fulminant hepatic failure with appropriate medical treatment....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics